Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.007 per share
-
Shares outstanding
-
28.7M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
119K
-
Shares change
-
+22.5K
-
Total reported value, excl. options
-
$140K
-
Value change
-
+$26.2K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$1.16
Significant Holders of bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) as of Q3 2023
10 filings reported holding BIAF - bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share as of Q3 2023.
bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 119K shares
of 28.7M outstanding shares and own 0.42% of the company stock.
Largest 10 shareholders include CAPTRUST FINANCIAL ADVISORS (43.6K shares), TWO SIGMA INVESTMENTS, LP (21.6K shares), VANGUARD GROUP INC (20K shares), STATE STREET CORP (17.6K shares), Creative Planning (12.1K shares), Tower Research Capital LLC (TRC) (4.05K shares), UBS Group AG (65 shares), Qube Research & Technologies Ltd (38 shares), WELLS FARGO & COMPANY/MN (38 shares), and JPMORGAN CHASE & CO (7 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.